Algenex

About:

Algenex is a developer of vector-based innovative technologies designed to manufacture recombinant proteins.

Website: http://www.algenex.com/

Top Investors: Cleon Capital, Vita Advisory

Description:

Algenex is a developer of vector-based innovative technologies designed to manufacture recombinant proteins. The company's technologies use a baculovirus expression vector system for vaccine manufacturing, diagnostic reagents, crystallography, HTS and therapeutic molecules.

Total Funding Amount:

4M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Pozuelo De Alarcón, Madrid, Spain

Founded Date:

2005-01-01

Contact Email:

administracion(AT)algenexcvt.cluster027.hosting.ovh.net

Founders:

José Ángel Escribano

Number of Employees:

1-10

Last Funding Date:

2019-03-06

IPO Status:

Private

Industries:

© 2025 bioDAO.ai